Cigna Group

For the period ended Dec 31, 2025. Filed Feb 26, 2026.

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 26, 2026

CI$295.60+0.7%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Contents

FS-2

STATEMENTS OF INCOME

	For the Years Ended December 31,
(In millions)	2025	2024	2023
Revenues
Net investment income and other revenue	$21	$26	$22
Intercompany interest income	469	469	516
Total revenues	490	495	538
Operating expenses
Selling, general and administrative expenses	5	14	2
Total operating expenses	5	14	2
lncome from operations	485	481	536
Interest expense and other	(1,365)	(1,388)	(1,332)
Gain on sale of businesses	4,890	—	—
Intercompany interest expense	—	(2)	(118)
lncome (loss) before income taxes	4,010	(909)	(914)
Income tax benefits	(201)	(189)	(192)
lncome (loss) of parent company	4,211	(720)	(722)
Equity in income of subsidiaries	1,746	4,154	5,886
Shareholders' net income	5,957	3,434	5,164
Shareholders' other comprehensive (loss) income, net of tax
Net unrealized (depreciation) appreciation on securities and derivatives	(238)	661	503
Net long-duration insurance and contractholder liabilities measurement adjustments	(291)	(1,067)	(715)
Net translation gains (losses) of foreign currencies	71	(49)	5
Postretirement benefits liability adjustment	(7)	(22)	1
Shareholders' other comprehensive loss, net of tax	(465)	(477)	(206)
Shareholders' comprehensive income	$5,492	$2,957	$4,958

FS-2

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.